Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent chemoradiotherapy plus consolidation chemotherapy for cervical cancer with para-aortic lymph node metastasis
ChiCTR1900020654Phase 2Recruiting
- Sponsor
- Yantai Yuhuangding Hospital
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin in Cervical Cancer (CC), sponsored by Yantai Yuhuangding Hospital. Primary endpoints: Disease-free progression survival (PFS), Overall survival (OS) and 1 more. Started Nov 2018; status: recruiting.
02
Drugs
cisplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ChiCTR1900020654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900020654.